Check nearby libraries
Buy this book
Maltase-glucoamylase (MGA) is an enzyme of glycoside hydrolase Family 31. It is an alpha-glucosidase anchored in the membrane of small intestinal epithelial cells responsible for the final step of mammalian starch digestion causing the release of glucose. Inhibitors targeting MGA and other alpha-glucosidases delay glucose production following digestion and are currently used in treatment of Type II diabetes. In an effort to discover new inhibitors that may aid in diabetes treatment and prevention, analogs of known inhibitors are being designed and synthesized. This thesis reports the use of Drosophila tissue culture for production and purification of active human recombinant MGA suitable for structural, kinetic and inhibition studies. Four promising inhibitors were discovered from a group of prospective inhibitors modeled after salacinol, a naturally occurring alpha-glucosidase inhibitor, and miglitol, a currently prescribed anti-diabetic. Future work will focus on the structural analysis of MGA as well as drug design for new anti-diabetics.
Check nearby libraries
Buy this book
Showing 1 featured edition. View all 1 editions?
Edition | Availability |
---|---|
1
Production, purification, and inhibition analysis of human maltase-glucoamylase using a Drosophila expression system.
2005
in English
0494075465 9780494075463
|
aaaa
Libraries near you:
WorldCat
|
Book Details
Edition Notes
Source: Masters Abstracts International, Volume: 44-02, page: 0779.
Thesis (M.Sc.)--University of Toronto, 2005.
Electronic version licensed for access by U. of T. users.
GERSTEIN MICROTEXT copy on microfiche (2 microfiches).
The Physical Object
ID Numbers
Community Reviews (0)
Feedback?January 24, 2010 | Edited by WorkBot | add more information to works |
December 11, 2009 | Created by WorkBot | add works page |